medicaid coverage glp 1 US states drop of GLP-1 weight-loss drugs as demand rises | US healthcare Biden administration plans to expand

doi: 10.1001/jamanetworkopen.2022.31982

Thats the focus of new research from investigators at Baylor Scott & White Research Institute and Stony Brook University Hospital , presented at the European Society of Cardiology (ESC) Congress 2025

Gastrointestinal symptomsincluding nausea, vomiting, dizziness and headachesare frequent, particularly during dose escalation

When paired with an individualized low-calorie, low-fat diet and a consistent exercise program, GLP-1 therapy can help improve various health markers in overweight adults including high blood pressure, diabetes, or high cholesterol reducing cardiovascular risk and improving metabolic health